Search

Begin New Search Topic International Cooperation Content Type Commentary and Analysis Publishing Institution George C. Marshall European Center for Security Studies Publication Year within 5 Years Publication Year within 10 Years

1. “Germany’s EU Presidency 2020: The Security Dimension and EU-NATO Cooperation”

Author:
Ralf Roloff
Publication Date:
07-2020
Content Type:
Commentary and Analysis
Institution:
George C. Marshall European Center for Security Studies
Abstract:
On July 1, 2020, Germany assumed the Presidency of the Council of the European Union for the second half of 2020. How Germany manages the EU Council presidency will be of utmost importance for the future of the European Union as well as for the transatlantic relationship. The German EU presidency faces two major challenges: first, containing the coronavirus crisis and working towards a European economic recovery and second, initiating a lasting dynamic towards European solidarity, and autonomy. How are the two challenges intertwined with security questions? Germany intends to promote closer EU-NATO security cooperation. The coronavirus pandemic has tested this envisaged cooperation, but also offered new opportunities. Hence, what is the pandemic’s impact on Germany’s ambitions for EU-NATO cooperation? On July 2, 2020, the Marshall Center brought together a group of experts and alumni from Belgium, Croatia, Germany, Hungary, Lithuania, Poland, Portugal, Romania, Slovakia, and the United States in a virtual workshop designed to share their expectations for Germany’s EU presidency as well as generate ideas about how to lay the groundwork for strengthening Euro-Atlantic security and EU-NATO cooperation going forward. The following takeaways are informed by the discussion.
Topic:
Defense Policy, NATO, International Cooperation, European Union, and Leadership
Political Geography:
Europe and Germany

2. With the World in Turmoil, Transnational Organized Crime Sees Opportunity in Counterfeit Pharmaceuticals and Medical Supplies during the COVID-19 Pandemic

Author:
Stephen Noguera and Kalliroi Ziavrou
Publication Date:
04-2020
Content Type:
Commentary and Analysis
Institution:
George C. Marshall European Center for Security Studies
Abstract:
The coronavirus disease (COVID-19) pandemic poses a host of global health, economic, and security challenges, to include the continued challenge of combating transnational organized crime. While some believe this pandemic will disrupt and have a negative impact on the global operations of transnational organized criminal groups, the morbid reality is that these groups view the crisis as a lucrative opportunity. For the foreseeable future, we can expect organized criminal groups to quickly adapt in order to exploit the pandemic via various illicit schemes. In Italy, mafia groups are already demonstrating that they are intent on benefiting from the crime-related opportunities that the COVID-19 pandemic will present.1 There are numerous opportunities and illicit ventures transnational organized crime will seek to exploit as this pandemic runs its course. Perhaps most concerning are the activities associated with the manufacture and trafficking of counterfeit pharmaceuticals and medical supplies, including personal protection equipment (PPE).2 Since the outbreak of the crisis, the sale of these products has increased.3 Interpol is warning that one of the five global threats from the coronavirus is the fraudulent and counterfeit trade in personal protective equipment and anti-viral pharmaceuticals.4 Moreover, during this crisis counterfeiters will most probably use shortages in the supply of some products to provide counterfeit alternatives.5 The European Medicines Agency (EMA) is urging the general public not to buy medicines from unauthorized websites and other vendors aiming to exploit fears and concerns during the ongoing pandemic of COVID-19. Such products are likely to be falsified medicines.6 According to the World Health Organization (WHO), “falsified” medicines are medical products that deliberately/fraudulently misrepresent their identity, composition, or source.7 For counterfeit products, the WHO is also using the terminology “substandard” (also called “out of specification”), for authorized medical products that fail to meet either their quality standards or specifications, or both, and “unregistered/unlicensed” for medical products that have not undergone evaluation and/or approval by the National or Regional Regulatory Authority (NRRA) for the market in which they are marketed/distributed or used, subject to permitted conditions under national or regional regulation and legislation.8
Topic:
International Cooperation, Public Health, Pandemic, COVID-19, and Medicine
Political Geography:
Europe